Living Language Lexicon of the Soteria Covenant
A drug developed to treat a rare disease affecting fewer than 200,000 people in the United States — eligible for special incentives including tax credits, market exclusivity, and reduced fees.
Submit a term for the community. Two endorsements from other members will publish it.